Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
NCT06508996 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1012
Last updated 2024-07-19
Summary
A multi-site prospective, all comers study that was conducted at geographically diverse locations in the United States.
Conditions
- HCV
Interventions
- DIAGNOSTIC_TEST
-
Xpert HCV
Detection of HCV RNA by Xpert HCV test
Sponsors & Collaborators
-
Emory University
collaborator OTHER -
Cepheid
lead INDUSTRY
Principal Investigators
-
Jennifer Havens · University of Kentucky College of Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-06
- Primary Completion
- 2024-05-10
- Completion
- 2024-06-06
Countries
- United States
Study Locations
More Related Trials
-
Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay Users
NCT06369116 ·Status: COMPLETED ·Phase: NA
-
Immune Response to Hepatitis C Virus
NCT00006301 ·Status: COMPLETED
-
INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation
NCT06357819 ·Status: COMPLETED
-
HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels
NCT04610762 ·Status: COMPLETED
-
HCV Test and Treat Utilizing Simplified HCV Patient Education
NCT05582681 ·Status: TERMINATED ·Phase: PHASE4
-
Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)
NCT01667081 ·Status: COMPLETED
-
Hepatitis C Antiviral Resistance in African-Americans
NCT00038974 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test
NCT00979979 ·Status: COMPLETED
-
Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions
NCT02333292 ·Status: COMPLETED
-
Evaluation Study of HCV RDTs in Fresh Samples
NCT04139941 ·Status: COMPLETED
-
Immune Response to Hepatitis C Virus
NCT00165919 ·Status: WITHDRAWN
-
MMF Influence on HCV Viral Evolution After Liver Transplantation
NCT00170131 ·Status: COMPLETED
-
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
NCT02609659 ·Status: COMPLETED ·Phase: PHASE3
-
Same-visit Hepatitis C Testing and Treatment (The QuickStart Study)
NCT05016609 ·Status: RECRUITING ·Phase: PHASE4
-
Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin
NCT00230854 ·Status: COMPLETED ·Phase: PHASE1
-
Study of CTS-1027 in Hepatitis C Patients
NCT00570336 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside
NCT03513796 ·Status: COMPLETED
-
Feasibility and Acceptability of HCV Treatment in Pregnancy
NCT06367465 ·Status: RECRUITING
-
Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)
NCT00895882 ·Status: WITHDRAWN ·Phase: PHASE2
-
Hepatitis C Diagnosis to Treatment Management
NCT05725109 ·Status: COMPLETED
-
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
NCT00735969 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004)
NCT00998985 ·Status: COMPLETED ·Phase: PHASE1
-
HCV Seek, Test and Rapid Treatment for Young PWID
NCT03627546 ·Status: COMPLETED ·Phase: NA
-
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
NCT02629172 ·Status: COMPLETED
-
A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir
NCT02103699 ·Status: COMPLETED